Maria Koehler

Insider Reports History

Entity
Individual
Location
C/O Repare Therapeutics Inc., 7210 Frederick Banting, Suite 100, St Laurent, Quebec, Canada
Signature
/s/ Mark Manfredi, as Attorney-in-Fact for Maria Koehler
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Maria Koehler:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Repare Therapeutics Inc. EVP, CHIEF MEDICAL OFFICER Common Shares 231K $1.08M $4.66 Apr 1, 2024 Direct
Repare Therapeutics Inc. EVP, CHIEF MEDICAL OFFICER Employee Stock Option (right to buy) 85K Mar 1, 2024 Direct
Silverback Therapeutics, Inc. Director Stock Option (right to buy) 18K Jun 10, 2022 Direct
Ikena Oncology, Inc. Director Stock Option (Right to Buy) 17.5K Jun 7, 2024 Direct

Insider Reports Filed by Maria Koehler

Symbol Company Period Transactions Value $ Form Type Date Filed Role
IKNA Ikena Oncology, Inc. Jun 7, 2024 1 $0 4 Jun 10, 2024 Director
RPTX Repare Therapeutics Inc. Mar 28, 2024 2 -$3.72K 4 Apr 1, 2024 EVP, CHIEF MEDICAL OFFICER
RPTX Repare Therapeutics Inc. Mar 25, 2024 3 -$7K 4 Mar 27, 2024 EVP, CHIEF MEDICAL OFFICER
RPTX Repare Therapeutics Inc. Mar 1, 2024 2 $0 4 Mar 4, 2024 EVP, CHIEF MEDICAL OFFICER
RPTX Repare Therapeutics Inc. Dec 11, 2023 4 $98.8K 4 Dec 12, 2023 EVP, Chief Medical Officer
IKNA Ikena Oncology, Inc. Jun 9, 2023 1 $0 4 Jun 13, 2023 Director
RPTX Repare Therapeutics Inc. Jan 30, 2023 2 $0 4 Feb 1, 2023 EVP, Chief Medical Officer
RPTX Repare Therapeutics Inc. Dec 20, 2022 4 $100K 4 Dec 20, 2022 EVP, Chief Medical Officer
SPRY Silverback Therapeutics, Inc. Jun 10, 2022 1 $0 4 Jun 13, 2022 Director
IKNA Ikena Oncology, Inc. Jun 9, 2022 1 $0 4 Jun 13, 2022 Director
RPTX Repare Therapeutics Inc. Jan 18, 2022 1 $0 4 Jan 20, 2022 EVP, Chief Medical Officer
IKNA Ikena Oncology, Inc. Dec 21, 2021 1 $0 4 Dec 23, 2021 Director
RPTX Repare Therapeutics Inc. Dec 10, 2021 4 $100K 4 Dec 10, 2021 EVP, Chief Medical Officer